Nav: Home

Too many businesses failing to properly embrace AI into processes, not reaping benefits

June 11, 2019

Businesses actively embracing artificial intelligence and striving to bring technological advancements into their operations are reaping dividends not seen by companies who fail to properly adapt and adopt.

While most business and technology leaders are optimistic about the value-creating potential of AI in their enterprise - Enterprise Cognitive Computing (ECC) - the actual rate of adoption is low, and benefits have proved elusive for a majority of organisations.

A study involving Lancaster University Management School's Centre for Technological Futures and MIT Sloan School's Center for Information Systems Research, published in MIT Sloan Management Review, examined adoption of ECC in 150 organisations from various industries across Europe, North America, Asia and Australia, to understand why.

Companies who are able to generate value from ECC do so having built a number of organisational capabilities. They develop skills for data science and algorithmic expertise, shape their business and the roles of staff to accommodate and integrate ECC initiatives, and account for the need to include human judgement and digital inquisitiveness in order to see benefits. Such businesses have strong domain expertise and a good operating IT infrastructure.

They apply these capabilities to a number of practices across the organisation, including co-creation involving people from across the business through the lifecycle of ECC applications, and developing use cases around pressing and meaningful business problems. They have strategies for managing and training AI algorithms within the ECC applications, and - importantly - they both create a positive buzz about ECC and at the same time have realistic and clear-eyed expectations of the benefits they can expect.

Professor Monideepa Tarafdar, Professor of Information Systems and Co-Director of the Centre for Technological Futures at Lancaster University, who co-authored the study, said: "Bringing AI successfully into a business has many positive effects. It can free employees to perform tasks that require adaptability and creativity found in human input, enhance operations, and augment employees' skills.

"But one of our studies showed half of companies have no ECC in place, and only half of those who have believe it to have produced measurable value. This suggests that generating value from such AI is not easy if organizations do not develop the needed capabilities and practices.

"Companies that are serious about AI applications spend the money to hire the right staff and develop the business practices that ensure ECC can improve their business operations, rather than spending money and harnessing massive amounts of data with no obvious benefits."

She added: "Having the proper capabilities in place enables employees to execute the new practices, and the practices in turn strengthen the capabilities of the ECC programmes. Such a virtuous cycle can lead to dramatic improvements in operational and financial performance, and customer satisfaction."

Lancaster University

Related Business Articles:

Great expectations force risky business acquisitions
A good reputation can be bad for business, according to new research from the University of Georgia.
Harnessing ADHD for business success
The symptoms of ADHD foster important traits associated with entrepreneurship.
From the Panama Papers to an intelligence service for your own business
In 2016 more than a hundred newspapers and others published revelations on tax avoidance and evasion.
OU study links entrepreneurial optimism with business success
Widespread collective entrepreneurial optimism in the United States is highly predictive of the number of new venture startups and small business growth, according to a University of Oklahoma study.
Business investment in innovation pays off
Firms need to invest in innovation in order to create new technologies and move the economy forward, according to new research from the University of Houston.
A new business model is needed to drive antibiotic development
The current business model for antibiotics is plagued by market failures and perverse incentives that both work against conservation efforts and provide insufficient rewards to drive the development of much-needed new treatments for resistant infection according to Kevin Outterson, from Boston University School of Law, Boston, US and Chatham House, UK, and colleagues in an Essay published in PLOS Medicine.
How to ride on brainwaves: From ideas to business
Anil Sethi started working for two cups of coffee per day when he began his first startup.
Asia Pacific: What lies ahead for its business leaders?
The Chinese market crash in January 2016 made an unsettling start to the New Year.
The real value of taking your business offshore
While it seems prestigious -- and tax-savvy -- to be based in the Cayman Islands or Luxembourg, companies that choose to do so aren't actually worth more, according to a new study published in the Journal of Corporate Finance.
Multinational companies perform majority of US business R&D
Multinational companies perform the majority of all research and development (R&D) done by companies located in the Unites States, according to a new report from the National Center for Science and Engineering Statistics.

Related Business Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...